As some cancer cells overexpress CD44 receptors capable of interacting with HA and TME is highly abundant in hyaluronidase (HAase), this platform could target CD44-overexpressed tumors and achieve the HAase-mediated release of DC to the cytoplasm to inhibit Glut1. This evidence concerns the gene SLC2A1 and cancer.